| COMPANY | TICKER | SEGMENT | HQ | THERAPY AREAS |
| 10X Genomics Inc | TXG | Emerging Public Biotech | Pleasanton, United States | |
| 4D Molecular Therapeutics Inc | FDMT | Emerging Public Biotech | EmeryVille, United States | |
| Aadi Bioscience | AADI | Emerging Public Biotech | California, USA | |
| Aardvark Therapeutics Inc | AARD | Emerging Public Biotech | San Diego, United States | Metabolic |
| Abbott | ABT | Big Pharma | Illinois, USA | |
| AbbVie | ABBV | Big Pharma | Illinois, USA | Immunology, oncology, neuroscience |
| Abcellera Biologics Inc | ABCL | Emerging Public Biotech | Vancouver, Canada | |
| Abivax | ABVX | Emerging Public Biotech | Paris, France | |
| Absci Corp | ABSI | Emerging Public Biotech | Vancouver, United States | |
| AC Immune SA | ACIU | Emerging Public Biotech | Lausanne, Switzerland | Neurology |
| Acadia Pharmaceuticals | ACAD | Emerging Public Biotech | California, USA | |
| Aclaris Therapeutics Inc | ACRS | Emerging Public Biotech | Wayne, United States | Immunology |
| Acorda Therapeutics | ACOR | Emerging Public Biotech | New York, USA | |
| Adaptive Biotechnologies Corp | ADPT | Emerging Public Biotech | Seattle, United States | Immunology |
| ADC Therapeutics SA | ADCT | Emerging Public Biotech | Epalinges, Switzerland | |
| Adma Biologics Inc | ADMA | Emerging Public Biotech | Ramsey, United States | Infectious Disease |
| Agios Pharmaceuticals | AGIO | Emerging Public Biotech | Massachusetts, USA | |
| Akebia Therapeutics Inc | AKBA | Emerging Public Biotech | Cambridge, United States | |
| Alkermes | ALKS | Large / Mid-cap Biopharma | Dublin, Ireland | |
| Allogene Therapeutics Inc | ALLO | Emerging Public Biotech | South San Francisco, United States | Oncology, Immunology |
| Alnylam | ALNY | Large / Mid-cap Biopharma | Massachusetts, USA | |
| Alpha Teknova Inc | TKNO | Emerging Public Biotech | Hollister, United States | |
| Altimmune Inc | ALT | Emerging Public Biotech | Gaithersburg, United States | Metabolic |
| Alto Neuroscience Inc | ANRO | Emerging Public Biotech | Mountain View, United States | Neurology |
| Alumis Inc | ALMS | Emerging Public Biotech | South San Francisco, United States | Immunology |
| Alvotech SA | ALVO | Emerging Public Biotech | Luxembourg, Luxembourg | Immunology |
| Amgen | AMGN | Big Pharma | California, USA | Oncology, inflammation, bone health |
| Amicus Therapeutics Inc | FOLD | Emerging Public Biotech | Princeton, United States | Rare Disease |
| Amneal | AMRX | Large / Mid-cap Biopharma | New Jersey, USA | |
| Amphastar Pharmaceuticals Inc | AMPH | Emerging Public Biotech | Rancho Cucamonga, United States | |
| Amylyx Pharmaceuticals Inc | AMLX | Emerging Public Biotech | Cambridge, United States | Neurology |
| Anaptysbio Inc | ANAB | Emerging Public Biotech | San Diego, United States | Immunology |
| Anavex Life Sciences Corp | AVXL | Emerging Public Biotech | New York, United States | Neurology |
| ANI Pharmaceuticals | ANIP | Emerging Public Biotech | Minnesota, USA | |
| Annexon Inc | ANNX | Emerging Public Biotech | Brisbane, United States | Immunology |
| Apellis Pharmaceuticals Inc | APLS | Emerging Public Biotech | Waltham, United States | |
| Apogee Therapeutics Inc | APGE | Emerging Public Biotech | Waltham, United States | Respiratory |
| Apotex | | Large / Mid-cap Biopharma | Toronto, Canada | |
| Arbutus Biopharma Corp | ABUS | Emerging Public Biotech | Warminster, United States | Infectious Disease |
| Arcellx Inc | ACLX | Emerging Public Biotech | Redwood City, United States | Oncology, Immunology |
| Arcturus Therapeutics Holdings Inc | ARCT | Emerging Public Biotech | San Diego, United States | Rare Disease, Respiratory |
| Arcus Biosciences Inc | RCUS | Emerging Public Biotech | Hayward, United States | Oncology |
| Arcutis Biotherapeutics Inc | ARQT | Emerging Public Biotech | Westlake Village, United States | Dermatology |
| Ardelyx | ARDX | Emerging Public Biotech | California, USA | |
| Argenx SE | ARGX | Emerging Public Biotech | Amsterdam, Netherlands | Immunology |
| Arrivent Biopharma Inc | AVBP | Emerging Public Biotech | Newtown Square, United States | Oncology |
| Ars Pharmaceuticals Inc | SPRY | Emerging Public Biotech | San Diego, United States | |
| Arvinas Inc | ARVN | Emerging Public Biotech | New Haven, United States | |
| Ascendis Pharma | ASND | Emerging Public Biotech | Copenhagen, Denmark | |
| Astellas | 4503 | Large / Mid-cap Biopharma | Tokyo, Japan | |
| AstraZeneca | AZN | Big Pharma | Cambridge, UK | Oncology, cardiovascular, renal & metabolism |
| Atai Life Sciences | ATAI | Emerging Public Biotech | New York, United States | |
| Atea Pharmaceuticals Inc | AVIR | Emerging Public Biotech | Boston, United States | Infectious Disease |
| Aura Biosciences Inc | AURA | Emerging Public Biotech | Boston, United States | Oncology |
| Aurinia Pharmaceuticals Inc | AUPH | Emerging Public Biotech | Edmonton, Canada | Immunology |
| Autolus Therapeutics | AUTL | Emerging Public Biotech | London, United Kingdom | Oncology, Immunology |
| AVEO Oncology | AVEO | Emerging Public Biotech | Massachusetts, USA | |
| Axsome Therapeutics Inc | AXSM | Large / Mid-cap Biopharma | New York, United States | Neurology |
| Bausch Health | BHC | Large / Mid-cap Biopharma | Quebec, Canada | |
| Bayer | BAYN | Big Pharma | Leverkusen, Germany | Cardiovascular, oncology, women's health |
| BeiGene | BGNE | Chinese Biopharma | Beijing, China | Oncology, Hematology |
| Beone Medicines AG | ONC | Emerging Public Biotech | Basel, Switzerland | Oncology |
| Bicara Therapeutics Inc | BCAX | Emerging Public Biotech | Boston, United States | Oncology |
| Bicycle Therapeutics | BCYC | Emerging Public Biotech | Cambridge, United Kingdom | |
| Bioage Labs Inc | BIOA | Emerging Public Biotech | Emeryville, United States | Metabolic |
| BioCryst | BCRX | Emerging Public Biotech | Indiana, USA | |
| Biogen | BIIB | Large / Midcap Biopharma | Massachusetts, USA | Neurology, neurodegeneration |
| Biohaven Ltd | BHVN | Emerging Public Biotech | New Haven, United States | Oncology, Neurology, Immunology |
| BioMarin | BMRN | Large / Mid-cap Biopharma | California, USA | |
| BioNTech SE | BNTX | Emerging Public Biotech | Mainz, Germany | Immunology |
| Blueprint Medicines | BPMC | Large / Mid-cap Biopharma | Massachusetts, USA | |
| Boehringer Ingelheim | | Big Pharma | Ingelheim, Germany | Respiratory, cardiometabolic, immunology |
| Bridgebio Oncology Therapeutics Inc | BBOT | Emerging Public Biotech | South San Francisco, United States | Oncology |
| Bridgebio Pharma Inc | BBIO | Emerging Public Biotech | Palo Alto, United States | |
| Bristol Myers Squibb | BMY | Big Pharma | New Jersey, USA | Oncology, immunology, cardiovascular |
| C4 Therapeutics Inc | CCCC | Emerging Public Biotech | Watertown, United States | |
| Cambrex | | Large / Mid-cap Biopharma | New Jersey, USA | |
| Cargo Therapeutics Inc | CRGX | Emerging Public Biotech | USA | |
| Catalyst Pharmaceuticals Inc | CPRX | Emerging Public Biotech | Coral Gables, United States | Rare Disease |
| Celcuity Inc | CELC | Emerging Public Biotech | Minneapolis, United States | Oncology |
| Celldex Therapeutics Inc | CLDX | Emerging Public Biotech | Hampton, United States | Immunology |
| Cellectis | CLLS | Emerging Public Biotech | Paris, France | |
| Centessa Pharmaceuticals | CNTA | Emerging Public Biotech | Altrincham, United Kingdom | Neurology |
| Cg Oncology Inc | CGON | Emerging Public Biotech | Irvine, United States | Oncology |
| Chiesi | | Large / Mid-cap Biopharma | Parma, Italy | |
| Cogent Biosciences Inc | COGT | Emerging Public Biotech | Waltham, United States | |
| Coherus BioSciences | CHRS | Emerging Public Biotech | California, USA | |
| Collegium Pharmaceutical Inc | COLL | Emerging Public Biotech | Stoughton, United States | |
| Compass Pathways | CMPS | Emerging Public Biotech | London, United Kingdom | |
| Compass Therapeutics Inc | CMPX | Emerging Public Biotech | Boston, United States | Oncology |
| Concordia | | Large / Mid-cap Biopharma | Toronto, Canada | |
| Contineum Therapeutics Inc | CTNM | Emerging Public Biotech | San Diego, United States | Neurology, Immunology |
| Corcept Therapeutics | CORT | Emerging Public Biotech | California, USA | |
| Cormedix Inc | CRMD | Emerging Public Biotech | Parsippany, United States | |
| Corvus Pharmaceuticals Inc | CRVS | Emerging Public Biotech | South San Francisco, United States | |
| Crinetics Pharmaceuticals Inc | CRNX | Emerging Public Biotech | San Diego, United States | Rare Disease |
| CSL Behring | CSL | Large / Mid-cap Biopharma | Melbourne, Australia | |
| Cullinan Therapeutics Inc | CGEM | Emerging Public Biotech | Cambridge, United States | Oncology, Immunology |
| Cytokinetics | CYTK | Emerging Public Biotech | California, USA | |
| Cytomx Therapeutics Inc | CTMX | Emerging Public Biotech | South San Francisco, United States | Oncology |
| Daiichi Sankyo | 4568 | Large / Mid-cap Biopharma | Tokyo, Japan | |
| Damora Therapeutics Inc | DMRA | Emerging Public Biotech | Waltham, United States | Hematology |
| Day One Biopharmaceuticals Inc | DAWN | Emerging Public Biotech | Brisbane, United States | |
| Definium Therapeutics Inc | DFTX | Emerging Public Biotech | New York, United States | Neurology |
| Denali Therapeutics | DNLI | Emerging Public Biotech | California, USA | Neuroscience, neurodegeneration |
| Design Therapeutics Inc | DSGN | Emerging Public Biotech | Carlsbad, United States | |
| Dianthus Therapeutics Inc | DNTH | Emerging Public Biotech | New York, United States | Immunology |
| Disc Medicine Inc | IRON | Emerging Public Biotech | Watertown, United States | |
| Dr Reddys | RDY | Large / Mid-cap Biopharma | Hyderabad, India | |
| Dyne Therapeutics Inc | DYN | Emerging Public Biotech | Waltham, United States | Neurology |
| Edgewise Therapeutics Inc | EWTX | Emerging Public Biotech | Boulder, United States | |
| Editas Medicine Inc | EDIT | Emerging Public Biotech | Cambridge, United States | |
| Eli Lilly | LLY | Big Pharma | Indiana, USA | Diabetes, Obesity, Oncology |
| Emergent Biosolutions Inc | EBS | Emerging Public Biotech | Gaithersburg, United States | |
| Enanta Pharmaceuticals Inc | ENTA | Emerging Public Biotech | Watertown, United States | Immunology |
| Endo Pharmaceuticals | ENDP | Large / Mid-cap Biopharma | Pennsylvania, USA | |
| Enliven Therapeutics Inc | ELVN | Emerging Public Biotech | Boulder, United States | Oncology |
| Entrada Therapeutics Inc | TRDA | Emerging Public Biotech | Boston, United States | |
| Erasca Inc | ERAS | Emerging Public Biotech | San Diego, United States | Oncology |
| Esperion Therapeutics | ESPR | Emerging Public Biotech | Michigan, USA | |
| Evolus Inc | EOLS | Emerging Public Biotech | Newport Beach, United States | |
| Exelixis | EXEL | Large / Mid-cap Biopharma | California, USA | |
| Eyepoint Pharmaceuticals Inc | EYPT | Emerging Public Biotech | Watertown, United States | |
| Foghorn Therapeutics Inc | FHTX | Emerging Public Biotech | Watertown, United States | |
| Fresenius Kabi | FRE | Large / Mid-cap Biopharma | Bad Homburg, Germany | |
| Fulcrum Therapeutics Inc | FULC | Emerging Public Biotech | Cambridge, United States | |
| Galapagos NV | GLPG | Emerging Public Biotech | Mechelen, Belgium | Oncology, Immunology, Metabolic |
| Genmab | GMAB | Large / Mid-cap Biopharma | Copenhagen, Denmark | Oncology |
| Geron | GERN | Emerging Public Biotech | California, USA | |
| GH Research | GHRS | Emerging Public Biotech | Dublin, Ireland | |
| Gilead Sciences | GILD | Big Pharma | California, USA | HIV, viral hepatitis, oncology |
| GlaxoSmithKline (GSK) | GSK | Big Pharma | London, UK | |
| Global Blood Therapeutics | GBT | Emerging Public Biotech | California, USA | |
| Gossamer Bio Inc | GOSS | Emerging Public Biotech | San Diego, United States | Cardiovascular, Respiratory |
| Grifols SA | GRFS | Emerging Public Biotech | Barcelona, Spain | |
| Halozyme Therapeutics Inc | HALO | Emerging Public Biotech | San Diego, United States | |
| Harmony Biosciences | HRMY | Emerging Public Biotech | Plymouth Meeting, United States | Neurology, Rare Disease |
| Harrow Inc | HROW | Emerging Public Biotech | Nashville, United States | |
| Hengrui Medicine | 600276.SS | Chinese Biopharma | Lianyungang, China | Oncology, Immunology, Cardiovascular |
| Heron Therapeutics | HRTX | Emerging Public Biotech | California, USA | |
| Hikma | HIK.L | Large / Mid-cap Biopharma | London, UK | |
| Horizon Therapeutics | HZNP | Large / Mid-cap Biopharma | Dublin, Ireland | |
| Humacyte Inc | HUMA | Emerging Public Biotech | Durham, United States | |
| HUTCHMED | HCM | Chinese Biopharma | Hong Kong, China | Oncology, Immunology |
| Ideaya Biosciences Inc | IDYA | Emerging Public Biotech | South San Francisco, United States | Oncology |
| Immuneering Corp | IMRX | Emerging Public Biotech | Cambridge, United States | Oncology |
| Immunitybio Inc | IBRX | Emerging Public Biotech | San Diego, United States | Immunology |
| Immunocore Holdings | IMCR | Emerging Public Biotech | Abingdon, United Kingdom | Oncology, Immunology, Infectious Disease |
| Immunome Inc | IMNM | Emerging Public Biotech | Bothell, United States | Oncology, Immunology |
| Immunovant Inc | IMVT | Emerging Public Biotech | New York, United States | Immunology |
| Immutep | IMMP | Emerging Public Biotech | Sydney, Australia | Oncology, Immunology |
| Incyte | INCY | Large / Mid-cap Biopharma | Delaware, USA | Oncology, inflammation |
| Indivior | INDV | Large / Mid-cap Biopharma | Richmond, UK | |
| Inhibrx Biosciences Inc | INBX | Emerging Public Biotech | La Jolla, United States | |
| Innovent Biologics | 1801.HK | Chinese Biopharma | Suzhou, China | Oncology, Immunology, Metabolic |
| Innoviva Inc | INVA | Emerging Public Biotech | Burlingame, United States | |
| Ionis Pharmaceuticals | IONS | Large / Mid-cap Biopharma | California, USA | Neurology, cardiometabolic, rare diseases |
| Iovance Biotherapeutics Inc | IOVA | Emerging Public Biotech | San Carlos, United States | Oncology |
| Ipsen | IPN | Large / Mid-cap Biopharma | Paris, France | Oncology, rare diseases, neuroscience |
| Ironwood Pharmaceuticals Inc | IRWD | Emerging Public Biotech | Boston, United States | Rare Disease |
| Janux Therapeutics Inc | JANX | Emerging Public Biotech | San Diego, United States | Oncology, Immunology |
| Jazz Pharmaceuticals | JAZZ | Large / Mid-cap Biopharma | Dublin, Ireland | |
| Johnson & Johnson | JNJ | Big Pharma | New Jersey, USA | |
| Jyong Biotech Ltd | MENS | Emerging Public Biotech | New Taipei City, Taiwan | |
| Kalvista Pharmaceuticals Inc | KALV | Emerging Public Biotech | Framingham, United States | Rare Disease |
| Karyopharm | KPTI | Emerging Public Biotech | Massachusetts, USA | |
| Keros Therapeutics Inc | KROS | Emerging Public Biotech | Lexington, United States | |
| Kodiak Sciences Inc | KOD | Emerging Public Biotech | Palo Alto, United States | |
| Kura Oncology Inc | KURA | Emerging Public Biotech | San Diego, United States | Oncology |
| Kymera Therapeutics Inc | KYMR | Emerging Public Biotech | Watertown, United States | |
| Kyverna Therapeutics Inc | KYTX | Emerging Public Biotech | Emeryville, United States | Immunology |
| Larimar Therapeutics Inc | LRMR | Emerging Public Biotech | Bala Cynwyd, United States | Rare Disease |
| LB Pharmaceuticals Inc | LBRX | Emerging Public Biotech | New York, United States | Neurology |
| Legend Biotech | LEGN | Emerging Public Biotech | Somerset, United States | Oncology |
| Lenz Therapeutics Inc | LENZ | Emerging Public Biotech | Solana Beach, United States | |
| Lexeo Therapeutics Inc | LXEO | Emerging Public Biotech | New York, United States | |
| Ligand Pharmaceuticals | LGND | Emerging Public Biotech | California, USA | |
| Liquidia Corp | LQDA | Emerging Public Biotech | Morrisville, United States | Rare Disease, Cardiovascular, Respiratory |
| Lupin | LUPIN | Large / Mid-cap Biopharma | Mumbai, India | |
| Lyell Immunopharma Inc | LYEL | Emerging Public Biotech | South San Francisco, United States | Oncology, Immunology, Hematology |
| Madrigal Pharmaceuticals Inc | MDGL | Emerging Public Biotech | West Conshohocken, United States | Metabolic |
| Mallinckrodt | MNK | Large / Mid-cap Biopharma | Dublin, Ireland | |
| Mannkind Corp | MNKD | Emerging Public Biotech | Danbury, United States | |
| Maze Therapeutics Inc | MAZE | Emerging Public Biotech | South San Francisco, United States | Metabolic |
| Mbx Biosciences Inc | MBX | Emerging Public Biotech | Carmel, United States | Metabolic |
| MeiraGTx Holdings | MGTX | Emerging Public Biotech | New York, United States | |
| Merck | MRK | Big Pharma | New Jersey, USA | |
| Mesoblast | MESO | Emerging Public Biotech | Melbourne, Australia | |
| MiMedx Group Inc | MDXG | Emerging Public Biotech | Marietta, United States | |
| Mineralys Therapeutics Inc | MLYS | Emerging Public Biotech | Radnor, United States | |
| Mirati Therapeutics | MRTX | Emerging Public Biotech | California, USA | |
| Mirum Pharmaceuticals Inc | MIRM | Emerging Public Biotech | Foster City, United States | Rare Disease |
| Mitsubishi Tanabe | 4508 | Large / Mid-cap Biopharma | Osaka, Japan | |
| Moderna | MRNA | Large / Mid-cap Biopharma | Massachusetts, USA | Vaccines, infectious diseases, oncology |
| Monte Rosa Therapeutics Inc | GLUE | Emerging Public Biotech | Boston, United States | |
| Nektar Therapeutics | NKTR | Emerging Public Biotech | California, USA | |
| Neumora Therapeutics Inc | NMRA | Emerging Public Biotech | Watertown, United States | Neurology |
| Neurocrine Biosciences | NBIX | Large / Mid-cap Biopharma | California, USA | |
| Neurogene Inc | NGNE | Emerging Public Biotech | New York, United States | Neurology, Rare Disease |
| NewAmsterdam Pharma NV | NAMS | Emerging Public Biotech | Naarden, Netherlands | Cardiovascular, Metabolic |
| Novabridge Biosciences | NBP | Emerging Public Biotech | Rockville, United States | Oncology, Immunology |
| Novartis | NVS | Big Pharma | Basel, Switzerland | Oncology, immunology, cardiovascular |
| Novavax Inc | NVAX | Emerging Public Biotech | Gaithersburg, United States | Infectious Disease |
| Novo Nordisk | NVO | Big Pharma | Bagsværd, Denmark | Diabetes, obesity, rare endocrine disorders |
| Novocure Ltd | NVCR | Emerging Public Biotech | Baar, Switzerland | Oncology |
| Nurix Therapeutics Inc | NRIX | Emerging Public Biotech | Brisbane, United States | Oncology |
| Nuvalent Inc | NUVL | Emerging Public Biotech | Cambridge, United States | Oncology |
| Nuvation Bio Inc | NUVB | Emerging Public Biotech | New York, United States | Oncology |
| Ocugen Inc | OCGN | Emerging Public Biotech | Malvern, United States | |
| Ocular Therapeutix Inc | OCUL | Emerging Public Biotech | Bedford, United States | |
| Olema Pharmaceuticals Inc | OLMA | Emerging Public Biotech | San Francisco, United States | Oncology |
| Omeros Corp | OMER | Emerging Public Biotech | Seattle, United States | Immunology, Rare Disease |
| OmniAb Inc | OABI | Emerging Public Biotech | Emeryville, United States | |
| OPKO Health Inc | OPK | Emerging Public Biotech | Miami, United States | |
| Organon & Co | OGN | Emerging Public Biotech | Jersey City, United States | |
| Oric Pharmaceuticals Inc | ORIC | Emerging Public Biotech | South San Francisco, United States | Oncology |
| Oruka Therapeutics Inc | ORKA | Emerging Public Biotech | Menlo Park, United States | Immunology |
| Otsuka | 4578 | Large / Mid-cap Biopharma | Tokyo, Japan | |
| Pacira BioSciences Inc | PCRX | Emerging Public Biotech | Brisbane, United States | |
| Palvella Therapeutics Inc | PVLA | Emerging Public Biotech | Wayne, United States | Rare Disease, Dermatology |
| PepGen Inc | PEPG | Emerging Public Biotech | Boston, United States | Neurology |
| Perrigo | PRGO | Large / Mid-cap Biopharma | Dublin, Ireland | |
| Perspective Therapeutics Inc | CATX | Emerging Public Biotech | Seattle, United States | Oncology |
| Pfizer | PFE | Big Pharma | New York, USA | Oncology, vaccines, immunology |
| Pharvaris NV | PHVS | Emerging Public Biotech | Zug, Switzerland | Rare Disease |
| Phathom Pharmaceuticals Inc | PHAT | Emerging Public Biotech | Florham Park, United States | |
| Praxis Precision Medicines Inc | PRAX | Emerging Public Biotech | Boston, United States | Neurology |
| Precigen Inc | PGEN | Emerging Public Biotech | Germantown, United States | Oncology, Immunology |
| Prestige Consumer Healthcare Inc | PBH | Emerging Public Biotech | Tarrytown, United States | |
| Prime Medicine Inc | PRME | Emerging Public Biotech | Cambridge, United States | |
| Prothena Corp | PRTA | Emerging Public Biotech | Dublin, Ireland | |
| PTC Therapeutics | PTCT | Emerging Public Biotech | New Jersey, USA | |
| Pyxis Oncology Inc | PYXS | Emerging Public Biotech | Boston, United States | Oncology |
| Radius Health | RDUS | Emerging Public Biotech | Massachusetts, USA | |
| Rapport Therapeutics Inc | RAPP | Emerging Public Biotech | Boston, United States | |
| Recursion Pharmaceuticals Inc | RXRX | Emerging Public Biotech | Salt Lake City, United States | |
| Regeneron | REGN | Large / Mid-cap Biopharma | New York, USA | |
| Regenxbio Inc | RGNX | Emerging Public Biotech | Rockville, United States | Rare Disease |
| Relay Therapeutics Inc | RLAY | Emerging Public Biotech | Cambridge, United States | |
| Repligen Corp | RGEN | Emerging Public Biotech | Waltham, United States | |
| Replimune Group Inc | REPL | Emerging Public Biotech | Woburn, United States | Oncology, Immunology |
| Revolution Medicines Inc | RVMD | Emerging Public Biotech | Redwood City, United States | Oncology |
| Rigel Pharmaceuticals Inc | RIGL | Emerging Public Biotech | South San Francisco, United States | Oncology, Hematology |
| Roche | ROG | Big Pharma | Basel, Switzerland | Oncology, immunology, neuroscience |
| Rocket Pharmaceuticals Inc | RCKT | Emerging Public Biotech | Cranbury, United States | Rare Disease |
| Roivant Sciences Ltd | ROIV | Emerging Public Biotech | London, United Kingdom | |
| Royalty Pharma | RPRX | Emerging Public Biotech | New York, United States | |
| Sana Biotechnology Inc | SANA | Emerging Public Biotech | Seattle, United States | |
| Sanofi | SAN | Big Pharma | Paris, France | Immunology, vaccines, rare diseases |
| Sarepta Therapeutics | SRPT | Large / Mid-cap Biopharma | Massachusetts, USA | Neuromuscular, rare diseases |
| Savara Inc | SVRA | Emerging Public Biotech | Langhorne, United States | Rare Disease, Respiratory |
| Scholar Rock Holding Corp | SRRK | Emerging Public Biotech | Cambridge, United States | Neurology, Rare Disease |
| Seagen | SGEN | Large / Mid-cap Biopharma | Washington, USA | |
| Sellas Life Sciences Group | SLS | Emerging Public Biotech | New York, United States | Oncology |
| Septerna Inc | SEPN | Emerging Public Biotech | South San Francisco, United States | Immunology |
| Silence Therapeutics | SLN | Emerging Public Biotech | London, United Kingdom | |
| Sionna Therapeutics Inc | SION | Emerging Public Biotech | Waltham, United States | |
| Soleno Therapeutics Inc | SLNO | Emerging Public Biotech | Redwood City, United States | Rare Disease |
| Solid Biosciences Inc | SLDB | Emerging Public Biotech | Charlestown, United States | Neurology |
| Spyre Therapeutics Inc | SYRE | Emerging Public Biotech | Waltham, United States | Immunology |
| Stoke Therapeutics Inc | STOK | Emerging Public Biotech | Bedford, United States | |
| Structure Therapeutics | GPCR | Emerging Public Biotech | South San Francisco, United States | |
| Sun Pharma | SUNPHARMA | Large / Mid-cap Biopharma | Mumbai, India | |
| Supernus Pharmaceuticals Inc | SUPN | Emerging Public Biotech | Rockville, United States | Neurology |
| Syndax Pharmaceuticals Inc | SNDX | Emerging Public Biotech | New York, United States | Oncology |
| Takeda | TAK | Big Pharma | Tokyo, Japan | Gastroenterology, Rare Disease |
| Tango Therapeutics Inc | TNGX | Emerging Public Biotech | Boston, United States | Oncology |
| Tarsus Pharmaceuticals Inc | TARS | Emerging Public Biotech | Irvine, United States | |
| Taysha Gene Therapies Inc | TSHA | Emerging Public Biotech | Dallas, United States | |
| Tectonic Therapeutic Inc | TECX | Emerging Public Biotech | Watertown, United States | |
| Tenaya Therapeutics Inc | TNYA | Emerging Public Biotech | South San Francisco, United States | Cardiovascular |
| Terns Pharmaceuticals Inc | TERN | Emerging Public Biotech | Foster City, United States | Oncology, Metabolic |
| Teva | TEVA | Big Pharma | Tel Aviv, Israel | |
| TG Therapeutics Inc | TGTX | Emerging Public Biotech | Morrisville, United States | |
| Theravance Biopharma Inc | TBPH | Emerging Public Biotech | South San Francisco, United States | |
| Third Harmonic Bio Inc | THRD | Emerging Public Biotech | USA | |
| Travere Therapeutics Inc | TVTX | Emerging Public Biotech | San Diego, United States | Rare Disease, Metabolic |
| Trevi Therapeutics Inc | TRVI | Emerging Public Biotech | New Haven, United States | Respiratory |
| Tyra Biosciences Inc | TYRA | Emerging Public Biotech | Carlsbad, United States | |
| UCB | UCB.BR | Large / Mid-cap Biopharma | Brussels, Belgium | Neurology, immunology |
| Ultragenyx | RARE | Emerging Public Biotech | California, USA | |
| Uniqure NV | QURE | Emerging Public Biotech | Amsterdam, Netherlands | Rare Disease |
| Upstream Bio Inc | UPB | Emerging Public Biotech | Waltham, United States | Immunology, Respiratory |
| UroGen Pharma Ltd | URGN | Emerging Public Biotech | Princeton, United States | Oncology |
| Vanda Pharmaceuticals Inc | VNDA | Emerging Public Biotech | Washington, United States | |
| Vaxcyte Inc | PCVX | Emerging Public Biotech | San Carlos, United States | Infectious Disease |
| Vera Therapeutics Inc | VERA | Emerging Public Biotech | Brisbane, United States | Immunology |
| Veracyte Inc | VCYT | Emerging Public Biotech | South San Francisco, United States | Oncology |
| Verastem Inc | VSTM | Emerging Public Biotech | Needham, United States | Oncology |
| Vericel Corp | VCEL | Emerging Public Biotech | Cambridge, United States | |
| Vertex Pharmaceuticals Inc | VRTX | Emerging Public Biotech | Boston, United States | |
| Viatris | VTRS | Large / Mid-cap Biopharma | Pennsylvania, USA | |
| Viking Therapeutics Inc | VKTX | Emerging Public Biotech | San Diego, United States | Metabolic |
| Vir Biotechnology Inc | VIR | Emerging Public Biotech | San Francisco, United States | Infectious Disease |
| Viridian Therapeutics Inc | VRDN | Emerging Public Biotech | Waltham, United States | Rare Disease |
| Vor Biopharma Inc | VOR | Emerging Public Biotech | Cambridge, United States | Oncology |
| Voyager Therapeutics Inc | VYGR | Emerging Public Biotech | Lexington, United States | Neurology, Rare Disease |
| Wave Life Sciences Ltd | WVE | Emerging Public Biotech | Singapore, Singapore | |
| Xencor Inc | XNCR | Emerging Public Biotech | Pasadena, United States | Oncology, Immunology |
| Xenon Pharmaceuticals Inc | XENE | Emerging Public Biotech | Burnaby, Canada | Neurology |
| Xeris Biopharma Holdings Inc | XERS | Emerging Public Biotech | Chicago, United States | Neurology |
| Zai Lab | ZLAB | Chinese Biopharma | Shanghai, China | Oncology, Immunology, Neurology |
| Zenas Biopharma Inc | ZBIO | Emerging Public Biotech | Waltham, United States | Immunology |
| Zevra Therapeutics Inc | ZVRA | Emerging Public Biotech | Boston, United States | Rare Disease |
| Zydus | ZYDUSLIFE | Large / Mid-cap Biopharma | Ahmedabad, India | |
| Zymeworks Inc | ZYME | Emerging Public Biotech | Middletown, United States | Oncology, Immunology |